Date: Tuesday, March 25, 1997 FOR IMMEDIATE RELEASE Contact: National Institutes of Health, NCI Press Office (301)496-6641
Prostate cancer is the most common nonskin cancer in American
men. Between 1973 and 1993, the rate of new cases of prostate
cancer rose by 173 percent, due partly to more widespread screening
for the disease and partly to the growing number of older men
in the U.S. population. It recently has begun to decline. During
1997, there will be about 334,000 new cases of prostate cancer.
Nearly 80 percent of these cases will be in men over the age of
65. There will be about 42,000 deaths.
Despite the rise in new cases, death rates for prostate cancer
have begun to decrease, down 6.2 percent between 1991 and 1995. The reasons for this decline
Radiation. Computerenhanced imaging techniques have
emerged. They help to better focus the beam of radiation onto
the tumor, away from healthy tissue.
New Treatment Options. Research has led to more types of
treatment for prostate cancer. These include blocking hormones
from the prostate that make the cancer grow; destroying a small
tumor by freezing it; and using an emerging technique of implanting
tiny radioactive pellets directly into the prostate to deliver
high doses of radiation to the tumor, without exposing other parts
of the body to the treatment.
Quality of Life. Scientists have found new ways to perform
surgery for prostate cancer. By sparing the nerves near the prostate,
doctors now can remove the prostate and reduce the chances that
the surgery will cause other health problems. Penile implants
or injections help men deal with impotence that can occur after
Race. Studies are under way to find out why men of some
races are more prone to prostate cancer than others. African American
men have the highest rate of prostate cancer in the world, while
Asian men have the lowest. Solving this mystery could lead to
new ways of preventing the disease for all races.
Diagnostics. Current studies will tell us more about whether to screen men for prostate cancer. We will know which men will be helped by having the cancer detected early. The studies also will suggest which treatments will be best for the different stages of the disease.
Drugs. Many studies are under way to evaluate compounds, such as retinoids and finasteride, that could lead to better ways to control or even prevent the disease.
Genetics. Scientists are searching for genes linked to
prostate cancer. Once they have identified these genes, researchers
can develop tests for those who want to know if they were born
with an altered gene that increases their chances of having prostate
cancer. Knowledge of the genes will also enable scientists to
look inside prostate cells and pinpoint the exact causes of cancer.
Treatment. Improved treatments for prostate cancer have
been developed. New studies will determine who will or will not
benefit from these treatments. They will also determine which
treatments are best in which situations.
Kirby R.S., et al. Prostate Cancer. Mosby, 1996.
Statistics are from the National Cancer Institute's
Surveillance, Epidemiology, and End Results (SEER) database (January
1997) and from the American Cancer Society's
Cancer Facts and Figures: 1997,
which contains estimates based on SEER data.
Cancer Information Service
The Cancer Information Service (CIS), a national information and education network, is a free public service of the National Cancer Institute (NCI), the federal government's primary agency for cancer research. The CIS meets the information needs of patients, the public, and health professionals. Specially trained staff provide the latest scientific information in understandable language. CIS staff answer questions in English and Spanish and distribute NCI materials.
Toll-free phone number: 1-800-4-CANCER (1-800-422-6237)
For NCI information by fax, dial 301-402-5874 from the telephone on a fax machine and listen to recorded instructions.
For NCI information by computer:
CancerNet Mail Service (via E-mail)
To obtain a contents list, send E-mail to email@example.com with the word "help" in the body of the message.
CancerNet is also accessible via the Internet through the World
Wide Web (http://cancernet.nci.nih.gov) and Gopher (gopher://gopher.nih.gov)